Seagen

Where Will Pfizer Be in 5 Years?
Where Will Pfizer Be in 5 Years?
Motley Fool
Pfizer
COVID-19
Seagen
Flag link:
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Merck
Seagen
Astellas
urothelial cancer
clinical trials
bladder cancer
Padcev
Keytruda
Flag link:
Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics
Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics
Globe Newswire
Nurix Therapeutics
Seagen
protein degradation
cancer
antibody-drug conjugate
Flag link:
Genmab and Seagen’s TIVDAK trial meets primary endpoint
Genmab and Seagen’s TIVDAK trial meets primary endpoint
Clinical Trials Arena
Genmab
Seagen
Tivdak
clinical trials
cervical cancer
Flag link:
Seagen’s breast cancer therapy meets main goal in late-stage study
Seagen’s breast cancer therapy meets main goal in late-stage study
Medical Marketing and Media
Seagen
Tukysa
breast cancer
clinical trials
Flag link:
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Flag link:
Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'
Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'
Fierce Biotech
Seagen
Merck
antibody-drug conjugate
Flag link:
Pfizer shuffles R&D leadership to prepare for Seagen merger
Pfizer shuffles R&D leadership to prepare for Seagen merger
Fierce Biotech
Pfizer
R&D
M&A
Seagen
Flag link:
FTC seeks additional info on Pfizer's proposed takeover of Seagen
FTC seeks additional info on Pfizer's proposed takeover of Seagen
Reuters
FTC
Pfizer
Seagen
M&A
Flag link:
Biopharma buyouts bounce back
Biopharma buyouts bounce back
EP Vantage
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Flag link:
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen
Flag link:
Pfizer refiles Seagen deal paperwork with regulators
Pfizer refiles Seagen deal paperwork with regulators
BioPharma Dive
Pfizer
Seagen
FTC
M&A
Flag link:
Biotech M&A is picking back up - here are the latest deals
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Flag link:
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
BioSpace
Seagen
Adcetris
Hodgkin's lymphoma
clinical trials
Flag link:
Medicare sets next tranche of drugs to face price hike penalties
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Medicare
Inflation Reduction Act
drug pricing
Amgen
Sanofi
Seagen
Flag link:
'I don't have a checklist:' Seagen CEO talks about his next stop, Pfizer deal and the ADC landscape
'I don't have a checklist:' Seagen CEO talks about his next stop, Pfizer deal and the ADC landscape
Fierce Pharma
Seagen
Pharma CEOs
David Epstein
Pfizer
Flag link:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Flag link:
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Pfizer
debt
Seagen
M&A
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:

Pages